Results 41 to 50 of about 29,725 (304)
Treatment of Primary Pulmonary Aspergillosis: An Assessment of the Evidence. [PDF]
Aspergillus spp. are a group of filamentous molds that were first described due to a perceived similarity to an aspergillum, or liturgical device used to sprinkle holy water, when viewed under a microscope.
Stewart, Ethan R, Thompson, George R
core +3 more sources
Biofilm-forming capability of highly virulent, multidrug-resistant Candida auris [PDF]
The emerging multidrug-resistant yeast pathogen Candida auris has attracted considerable attention as a source of healthcare–associated infections. We report that this highly virulent yeast has the capacity to form antifungal resistant biofilms sensitive
Borman, Andrew +6 more
core +3 more sources
Caspofungin in the Treatment of Symptomatic Candiduria [PDF]
Because the urine concentrations achieved by echinocandin antifungal agents are low, drugs from this class are excluded from consideration when candiduria treatment is selected.We performed a retrospective view (sponsored by Merck Research Laboratories) of case records of patients participating in phase II-III clinical studies of caspofungin to ...
Jack D. Sobel +3 more
openaire +3 more sources
Caspofungin is the first echinocandin antifungal agent that licented for pediatric use in invasive candidiasis and aspergillosis. In this study, we evaluated the population pharmacokinetics of caspofungin and investigate appropriate dosing optimization ...
Chang-He Niu +7 more
doaj +1 more source
Candida albicans is a prevalent opportunistic human fungal pathogen. Echinocandins are first-line drugs for the treatment of invasive candidiasis. Molecular mechanisms of resistance to echinocandins have been extensively studied; however, the effect of ...
Lijun Zheng +5 more
doaj +1 more source
Medication Complications in Extracorporeal Membrane Oxygenation. [PDF]
The need for extracorporeal membrane oxygenation (ECMO) therapy is a marker of disease severity for which multiple medications are required. The therapy causes physiologic changes that impact drug pharmacokinetics.
Aebi +99 more
core +2 more sources
Management of a case of Candida albicans endogenous endophthalmitis with intravitreal caspofungin
We report a case of Candida albicans endogenous endophthalmitis treated with intravitreal caspofungin. The patient was a known case of acute lymphoblastic leukemia on chemotherapy and presented to us with features suggestive of endogenous endophthalmitis.
Harshali Manish Yadav +3 more
doaj +1 more source
Caspofungin Induced Cell Wall Changes of Candida Species Influences Macrophage Interactions
Candida species are known to differ in their ability to cause infection and have been shown to display varied susceptibilities to antifungal drugs. Treatment with the echinocandin, caspofungin, leads to compensatory alterations in the fungal cell wall ...
L. Walker, C. Munro
semanticscholar +1 more source
CASPOFUNGIN FOR CANDIDA ENDOCARDITIS
Wojciech Mrówczyński, Michał Wojtalik
openalex +3 more sources
Pharmacokinetics and Safety of Intravitreal Caspofungin [PDF]
ABSTRACT Caspofungin exhibits potent antifungal activities against Candida and Aspergillus species. The elimination rate and retinal toxicity of caspofungin were determined in this study to assess its pharmacokinetics and safety in the treatment of fungal endophthalmitis ...
Ying-Cheng Shen +6 more
openaire +3 more sources

